| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $6K | -13.7% |
| SG&A Expense | $15K | +9.9% |
| Operating Income | -$99K | +36.4% |
| Net Income | -$99K | +36.4% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14 | +133.3% |
| Current Assets | $14 | +133.3% |
| Total Assets | $14 | +133.3% |
| Current Liabilities | $2.4M | +4.3% |
| Total Liabilities | $2.4M | +4.3% |
| Stockholders' Equity | -$2.4M | -4.3% |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31K | +17.9% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $31K | -17.3% |